天士力(600535.SH)：药品温经汤颗粒获得药品注册证书

Core Viewpoint - Tianshili (600535.SH) has received a drug registration certificate from the National Medical Products Administration for its product, Wengjing Decoction Granules, which enhances blood circulation and alleviates pain, particularly for women experiencing menstrual irregularities and abdominal pain [1] Summary by Categories Product Development - The company has invested a total of 10.72 million RMB in the research and development of Wengjing Decoction Granules [1] Market Positioning - The approval of Wengjing Decoction Granules enriches the company's portfolio in traditional Chinese medicine products [1]